Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 301 AL 315

Passive amyloid-β immunotherapy in Alzheimer's disease: a multicellular clearance system beyond plaque removal

Zhan X, Liu C, Yu C, Lindblom N, Deierborg T, Kobro-Flatmoen A, Gouras GK, Wen G.

Mol Neurodegener. 2026 Jul 16;21(1):37. doi: 10.1186/s13024-026-00972-y.

Standardizing care for agitation in Alzheimer's disease, results from a randomized controlled trial of an integrated care pathway versus usual care - the StaN trial

Kumar S, Burhan AM, Colman S, Chu L, Davies S, Derkach P, Elmi S, Gerretsen P, Graff-Guerrero A, Greenway K, Hussain M, Ismail Z, Kim D, Krisman L, Ma C, Moghabghab R, Mulsant BH, Pollock BG, Rej S, Rostas A, Schoer N, Streiner DL, Van Bussel L, Rajji TK; StaN Study Group.

Alzheimers Dement. 2026 Jul;22(7):e71610. doi: 10.1002/alz.71610.

Long-term safety and immunogenicity of ABvac40 active immunotherapy in mild cognitive impairment and very mild Alzheimer's disease: Results from AB1601 phase 2 extension study

Pascual-Lucas M, Lacosta AM, Montañés M, Canudas J, Loscos J, Monleón I, Allué JA, Sarasa L, Fandos N, Romero J, Sarasa M, Torres M, Whyms D, Terencio J, Piñol-Ripoll G, Boada M.

Alzheimers Dement. 2026 Aug;22(8):e71746. doi: 10.1002/alz.71746.

rTMS modulates early AD progression via synergistic brain network reorganization and peripheral biomarker dynamics

Wang T, Guo M, Wu H, Liu S, Ji Y, Wang P, Xu G.

Geroscience. 2026 Jun;48(3):4295-4311. doi: 10.1007/s11357-025-01888-z. Epub 2025 Sep 27.

Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study

Li LL, Wang RZ, Wang Z, Hu H, Xu W, Zhu L, Sun Y, Chen KL, Chen SF, He XY, Yuan MY, Huang YY, Liu XY, Liu P, Ye QY, Wang J, Ju ZZ, Zhang W, Hu B, Guo Y, Cao XY, Li YX, Zuo CT, Cheng W, Jiang T, Tan L, Chen XC, Zhao QH, Cui M, Peng GP, Xin JW, Yu JT.

Brain. 2026 Jun 3;149(6):1973-1985. doi: 10.1093/brain/awaf427.

Alzheimer's disease diagnosis: An update and review of biomarkers, positron emission tomography, and emerging therapies

Chen PH, Hsu JL.

J Formos Med Assoc. 2026 Jun;125 Suppl 1:S13-S16. doi: 10.1016/j.jfma.2026.01.035. Epub 2026 Jan 27.

Cerebrospinal fluid biomarkers in Alzheimer's disease: enhancing diagnostic precision and guiding therapeutic strategies

Azadovich AP, Oralov B, Sherzod K, Kudeshova G, Feruza A, Umida B, Kambarova O, Farkhod R, Baxtiyor S, Jurabek Y, Narzikulova K, Nazirova S, Egamberdieva S.

Clin Chim Acta. 2026 Jul 15;589:121010. doi: 10.1016/j.cca.2026.121010. Epub 2026 Apr 16.

Dietary intervention and cognition across Alzheimer's disease biomarker levels: The MIND clinical trial

Dhana K, Aggarwal NT, Arfanakis K, Sacks FM, Barnes LL.

J Alzheimers Dis. 2026 Jun;111(3):1301-1308. doi: 10.1177/13872877261442856. Epub 2026 Apr 25.

The gut-brain axis in Alzheimer's and Parkinson's diseases: a systematic review of microbiota-derived biomarkers and novel therapeutic approaches

Singh VK, Gupta P, Jain SK, Matreja PS.

J Clin Exp Neuropsychol. 2026 Aug;48(6):606-621. doi: 10.1080/13803395.2026.2673084. Epub 2026 Jun 2.

The role of YKL-40 in Alzheimer's disease pathology and drug targeting

Sha Y, Fu H, Lu K, Wang G, Wang Y.

PeerJ. 2026 Jun 8;14:e21361. doi: 10.7717/peerj.21361. eCollection 2026.

Impacts of menopausal hormone therapy on Alzheimer's disease biomarkers: A systematic review

Rodrigues AC, Valério FG, Moura CB, Da Silva AMP, Tudella GCN, Almeida SS, Gomes AC, Oliveira CEM, Apóstolos-Pereira SL, Santos DH.

J Alzheimers Dis. 2026 Aug;112(3):1143-1158. doi: 10.1177/13872877261456766. Epub 2026 Jun 16.

Alzheimer's Disease and MERC Dysfunction: Integrating Mechanisms, Biomarkers, and Therapeutic Strategies

Kashif M, Majumder D.

Mol Neurobiol. 2026 Jun 18;63(1):701. doi: 10.1007/s12035-026-06009-1.

Clinico-biological trajectories stratified by combined tau biomarkers in preclinical Alzheimer's disease

Labrador-Espinosa MA, Franzmeier N, Karagianni S, Moscoso A, Schöll M.

Alzheimers Res Ther. 2026 Jun 24;18(1):154. doi: 10.1186/s13195-026-02123-3.

Targeting the pathological tau N368 fragment: A pharmacological perspective on a novel immunotherapy for Alzheimer's disease

Qian Z, Hu Z, Li Y, Zuo D, He R, Ye K.

Pharmacol Res. 2026 Sep;231:108337. doi: 10.1016/j.phrs.2026.108337. Epub 2026 Jul 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias